Conferences

Reports related to pediatric cancers from professional meetings.

Results of a Prospective Study Delivering Limited Margin Radiotherapy for Pediatric Patients with Ewing’s Sarcoma Family of Tumors
Presenter: M.J. KrasinPresenter's Affiliation: St. Jude Children’s Research Hospital, Memphis, TNType of Session: ScientificBackground The Ewing’s sarcoma represents the 2nd most common bone tumor in children, following osteosarcoma. The Ewing’s sarcoma family of tumors includes Ewing’s sarcoma of

Second Tumors in Pediatric Patients Treated with Radiotherapy to the Central Nervous System
Presenter: Thomas GallowayPresenter's Affiliation: University of Florida Shands Cancer Center, Gainesville, FLType of Session: ScientificBackground Second malignant neoplasm (SMN) is a well-recognized risk of cancer treatments, including radiotherapy and chemotherapy, and this risk has been demonstrated to be increased in

New Chemotherapy Combination Causes Brain Tumors to Regress
Researchers have found that a chemotherapy regimen, including procarbazine, CCNU and Vincristine (PVC), given before radiation therapy to patients with low-grade oligodendroglioma or oligoastrocytoma brain tumors, causes tumors to regress in 28 percent of patients. Jan Buckner, MD, medical oncologist at Mayo Clinic and colleagues entered 31

7th National Brain Tumor Conference
Conference Dates: September 20-21, 2002 Conference Location: San Francisco Bay Area, Denver, Phoenix Sponsoring Group: National Brain Tumor Foundation Conference Web Page URL: http://www.braintumor.org/pservices/wnnewsletter.asp Topics Covered: Symptom management, new treatments, understanding diagnostics, long term issues, research

Brain Tumor Action Week Symposium
Conference Dates: May 8, 2003 Conference Location: Medical Alumni Hall, Philadelphia, PA Sponsoring Group: Division of Neuro-Oncology Topics Covered: Presentation(s) from Department(s) of Neurosurgery, Neuro-Oncology, Radiation-Oncology, and Rehabilitation from UPHS. Further, panel members will represent Children's Hospital of

Pediatric Cancers

Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors
Presenter: TE Merchant, MD Affiliation: St. Jude Children's Research Hospital, Memphis, TN Background: Use of Conformal Radiation Therapy (CRT) for treatment of pediatric brain tumors has the potential for reducing toxicity and improving the therapeutic ratio.Ê The results of such treatment, and the relationships between dose,

Advances in Pediatric Hematology/Oncology
Date: November 14-16, 2001 Location: Clearwater Beach, Florida, USA Symposium Web Page: www.moffitt.usf.edu/faptp Sponsors: Florida Association of Pediatric Tumor Programs Who Should Attend: Health care professionals working in pediatric hematology and oncology Objectives: Learn the latest treatments and trends in childhood

Expression Profiling of Pediatric Acute Lymphoblastic Leukemia (ALL) Blasts at Diagnosis Accurately Predicts both the Risk of Relapse and of Developing Therapy-Induced ALL
Presenter: E. Yeoh PresentAer's Affiliation: National University of Singapore Type of Session: Plenary Background Pediatric patients with ALL (PALL) are typically stratified into risk groups to help direct therapy. 80% of patients are now cured of pediatric ALL with systemic chemotherapy and treatment of the CNS. Despite this high cure

Isolated CNS relapse of acute lymphoblastic leukemia (ALL) treated with intensive systemic chemotherapy and delayed CNS radiation: A Pediatric Oncology Group Study
Presenter: J.C. BarredoPresenter's Affiliation: Medical University of South CarolinaType of Session: ScientificBackground Event-free survival for patients suffering isolated CNS relapse of ALL after initial therapy has improved. The previous POG 9061 study showed an excellent 4 year EFS of 71% with 6 months of intensive chemotherapy and delayed

Results from a phase II trial of conformal radiation therapy (CRT)for pediatric patients with localized ependymoma and quantification of radiation-related CNS effects
Presenter: T.E. MerchantPresenter's Affiliation: St. Jude Children's Research HospitalType of Session: ScientificBackground Radiation therapy (RT) following maximal resection is the standard treatment for localized ependymoma in children. In very young children, avoiding or delaying RT with systemic chemotherapy has been justified by the